HEADER TRANSFERASE/TRANSFERASE INHIBITOR 21-JUN-15 5C5R TITLE CRYSTAL STRUCTURE OF HUMAN TANKYRASE-2 IN COMPLEX WITH A TITLE 2 PYRANOPYRIDONE INHIBITOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: TANKYRASE-2; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: UNP RESIDUES 946-1113; COMPND 5 SYNONYM: TANK2,ADP-RIBOSYLTRANSFERASE DIPHTHERIA TOXIN-LIKE 6,ARTD6, COMPND 6 POLY [ADP-RIBOSE] POLYMERASE 5B,TNKS-2,TRF1-INTERACTING ANKYRIN- COMPND 7 RELATED ADP-RIBOSE POLYMERASE 2,TANKYRASE II,TANKYRASE-LIKE PROTEIN, COMPND 8 TANKYRASE-RELATED PROTEIN; COMPND 9 EC: 2.4.2.30; COMPND 10 ENGINEERED: YES; COMPND 11 MOL_ID: 2; COMPND 12 MOLECULE: TANKYRASE-2; COMPND 13 CHAIN: C, D; COMPND 14 FRAGMENT: UNP RESIDUES 1114-1162; COMPND 15 SYNONYM: TANK2,ADP-RIBOSYLTRANSFERASE DIPHTHERIA TOXIN-LIKE 6,ARTD6, COMPND 16 POLY [ADP-RIBOSE] POLYMERASE 5B,TNKS-2,TRF1-INTERACTING ANKYRIN- COMPND 17 RELATED ADP-RIBOSE POLYMERASE 2,TANKYRASE II,TANKYRASE-LIKE PROTEIN, COMPND 18 TANKYRASE-RELATED PROTEIN; COMPND 19 EC: 2.4.2.30; COMPND 20 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: TNKS2, PARP5B, TANK2, TNKL; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 MOL_ID: 2; SOURCE 9 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 10 ORGANISM_COMMON: HUMAN; SOURCE 11 ORGANISM_TAXID: 9606; SOURCE 12 GENE: TNKS2, PARP5B, TANK2, TNKL; SOURCE 13 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 14 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS WNT-SIGNALLING, BETA-CATENIN, PARP-DOMAIN, ADP-RIBOSYLATION, AXIN, KEYWDS 2 TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR C.M.LUKACS,C.A.JANSON REVDAT 4 27-SEP-23 5C5R 1 REMARK REVDAT 3 22-NOV-17 5C5R 1 REMARK REVDAT 2 07-OCT-15 5C5R 1 JRNL REVDAT 1 12-AUG-15 5C5R 0 JRNL AUTH J.DE VICENTE,P.TIVITMAHAISOON,P.BERRY,D.R.BOLIN,D.CARVAJAL, JRNL AUTH 2 W.HE,K.S.HUANG,C.JANSON,L.LIANG,C.LUKACS,A.PETERSEN,H.QIAN, JRNL AUTH 3 L.YI,Y.ZHUANG,J.C.HERMANN JRNL TITL FRAGMENT-BASED DRUG DESIGN OF NOVEL PYRANOPYRIDONES AS CELL JRNL TITL 2 ACTIVE AND ORALLY BIOAVAILABLE TANKYRASE INHIBITORS. JRNL REF ACS MED.CHEM.LETT. V. 6 1019 2015 JRNL REFN ISSN 1948-5875 JRNL PMID 26396691 JRNL DOI 10.1021/ACSMEDCHEMLETT.5B00251 REMARK 2 REMARK 2 RESOLUTION. 1.55 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNX 2005 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN,ACCELRYS REMARK 3 : SOFTWARE INC.(BADGER,BERARD,KUMAR,SZALMA, REMARK 3 : YIP,DZAKULA) REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.55 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 49.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 2156381.580 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0000 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 98.8 REMARK 3 NUMBER OF REFLECTIONS : 76896 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.188 REMARK 3 R VALUE (WORKING SET) : 0.188 REMARK 3 FREE R VALUE : 0.202 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 3851 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.003 REMARK 3 REMARK 3 FIT/AGREEMENT OF MODEL WITH ALL DATA. REMARK 3 R VALUE (WORKING + TEST SET, NO CUTOFF) : 0.2100 REMARK 3 R VALUE (WORKING SET, NO CUTOFF) : 0.2100 REMARK 3 FREE R VALUE (NO CUTOFF) : 0.220 REMARK 3 FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT (NO CUTOFF) : 3851 REMARK 3 ESTIMATED ERROR OF FREE R VALUE (NO CUTOFF) : 0.0040 REMARK 3 TOTAL NUMBER OF REFLECTIONS (NO CUTOFF) : 76896 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.55 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.65 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 98.90 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 12007 REMARK 3 BIN R VALUE (WORKING SET) : 0.2700 REMARK 3 BIN FREE R VALUE : 0.2820 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.30 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 669 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.011 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3338 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 54 REMARK 3 SOLVENT ATOMS : 521 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 20.20 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 22.00 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -1.11000 REMARK 3 B22 (A**2) : -3.98000 REMARK 3 B33 (A**2) : 5.09000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.17 REMARK 3 ESD FROM SIGMAA (A) : 0.13 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.19 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.13 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.375 REMARK 3 BOND ANGLES (DEGREES) : 1.900 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 20.70 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.910 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 1.270 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 2.030 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 2.080 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 3.200 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.35 REMARK 3 BSOL : 41.77 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARA REMARK 3 PARAMETER FILE 2 : LIG.PAR REMARK 3 PARAMETER FILE 3 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 4 : ION.PARAM REMARK 3 PARAMETER FILE 5 : &_1_PARAMETER_INFILE_5 REMARK 3 PARAMETER FILE 6 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : LIG.TOP REMARK 3 TOPOLOGY FILE 3 : WATER.TOP REMARK 3 TOPOLOGY FILE 4 : ION.TOP REMARK 3 TOPOLOGY FILE 5 : &_1_TOPOLOGY_INFILE_5 REMARK 3 TOPOLOGY FILE 6 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 5C5R COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 23-JUN-15. REMARK 100 THE DEPOSITION ID IS D_1000211065. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 15-OCT-10 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SLS REMARK 200 BEAMLINE : X10SA REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9999 REMARK 200 MONOCHROMATOR : SI(111) REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 77657 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.550 REMARK 200 RESOLUTION RANGE LOW (A) : 49.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.8 REMARK 200 DATA REDUNDANCY : 6.400 REMARK 200 R MERGE (I) : 0.06600 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 15.2000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.55 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.63 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.8 REMARK 200 DATA REDUNDANCY IN SHELL : 6.30 REMARK 200 R MERGE FOR SHELL (I) : 0.37100 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 4.300 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: CNX, CCP4 REMARK 200 STARTING MODEL: 3KR8 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 49.69 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.44 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 30-40% PEG 3350, 5% SATURATED AMMONIUM REMARK 280 SULFATE, 0.1M TRIS PH 8.5, VAPOR DIFFUSION, SITTING DROP, REMARK 280 TEMPERATURE 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 2 2 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -X,Y,-Z+1/2 REMARK 290 4555 X,-Y,-Z REMARK 290 5555 X+1/2,Y+1/2,Z REMARK 290 6555 -X+1/2,-Y+1/2,Z+1/2 REMARK 290 7555 -X+1/2,Y+1/2,-Z+1/2 REMARK 290 8555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 59.66700 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 59.66700 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 45.60250 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 49.05700 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 6 -1.000000 0.000000 0.000000 45.60250 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 49.05700 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 59.66700 REMARK 290 SMTRY1 7 -1.000000 0.000000 0.000000 45.60250 REMARK 290 SMTRY2 7 0.000000 1.000000 0.000000 49.05700 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 59.66700 REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 45.60250 REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 49.05700 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 6390 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 10510 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -68.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 6440 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 10380 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -67.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: B, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH B1358 LIES ON A SPECIAL POSITION. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 923 REMARK 465 HIS A 924 REMARK 465 HIS A 925 REMARK 465 HIS A 926 REMARK 465 HIS A 927 REMARK 465 HIS A 928 REMARK 465 HIS A 929 REMARK 465 SER A 930 REMARK 465 SER A 931 REMARK 465 GLY A 932 REMARK 465 VAL A 933 REMARK 465 ASP A 934 REMARK 465 LEU A 935 REMARK 465 GLY A 936 REMARK 465 THR A 937 REMARK 465 GLU A 938 REMARK 465 ASN A 939 REMARK 465 LEU A 940 REMARK 465 TYR A 941 REMARK 465 PHE A 942 REMARK 465 GLN A 943 REMARK 465 SER A 944 REMARK 465 MET A 945 REMARK 465 LEU A 946 REMARK 465 ASN A 947 REMARK 465 THR A 948 REMARK 465 SER A 949 REMARK 465 GLY A 950 REMARK 465 SER A 951 REMARK 465 MET A 1113 REMARK 465 GLY C 1162 REMARK 465 MET B 923 REMARK 465 HIS B 924 REMARK 465 HIS B 925 REMARK 465 HIS B 926 REMARK 465 HIS B 927 REMARK 465 HIS B 928 REMARK 465 HIS B 929 REMARK 465 SER B 930 REMARK 465 SER B 931 REMARK 465 GLY B 932 REMARK 465 VAL B 933 REMARK 465 ASP B 934 REMARK 465 LEU B 935 REMARK 465 GLY B 936 REMARK 465 THR B 937 REMARK 465 GLU B 938 REMARK 465 ASN B 939 REMARK 465 LEU B 940 REMARK 465 TYR B 941 REMARK 465 PHE B 942 REMARK 465 GLN B 943 REMARK 465 SER B 944 REMARK 465 MET B 945 REMARK 465 LEU B 946 REMARK 465 ASN B 947 REMARK 465 THR B 948 REMARK 465 SER B 949 REMARK 465 GLY B 950 REMARK 465 SER B 951 REMARK 465 ALA B 1112 REMARK 465 MET B 1113 REMARK 465 LYS D 1114 REMARK 465 GLY D 1162 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS C1114 CG CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 MET C1115 N MET C1115 CA 0.157 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 MET C1115 C - N - CA ANGL. DEV. = 22.1 DEGREES REMARK 500 MET C1115 CA - CB - CG ANGL. DEV. = 13.1 DEGREES REMARK 500 MET C1115 CB - CG - SD ANGL. DEV. = 23.0 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A1020 30.38 -99.84 REMARK 500 ASN A1022 35.46 72.83 REMARK 500 ASN B1020 58.55 -142.37 REMARK 500 HIS B1021 53.44 33.19 REMARK 500 HIS B1021 55.00 33.19 REMARK 500 VAL D1131 -57.33 -122.76 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A1510 DISTANCE = 6.77 ANGSTROMS REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 ZN A1201 ZN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 CYS A1081 SG REMARK 620 2 HIS A1084 ND1 109.7 REMARK 620 3 CYS A1089 SG 107.8 106.3 REMARK 620 4 CYS A1092 SG 118.5 102.1 111.7 REMARK 620 N 1 2 3 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 ZN B1201 ZN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 CYS B1081 SG REMARK 620 2 HIS B1084 ND1 110.3 REMARK 620 3 CYS B1089 SG 109.1 108.0 REMARK 620 4 CYS B1092 SG 119.1 99.0 110.5 REMARK 620 N 1 2 3 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue ZN A 1201 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 0E1 A 1202 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue SO4 A 1203 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue SO4 C 1201 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue ZN B 1201 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 0E1 B 1202 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue SO4 B 1203 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue SO4 D 1201 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 5C5P RELATED DB: PDB REMARK 900 RELATED ID: 5C5R RELATED DB: PDB DBREF 5C5R A 946 1113 UNP Q9H2K2 TNKS2_HUMAN 946 1113 DBREF 5C5R C 1114 1162 UNP Q9H2K2 TNKS2_HUMAN 1114 1162 DBREF 5C5R B 946 1113 UNP Q9H2K2 TNKS2_HUMAN 946 1113 DBREF 5C5R D 1114 1162 UNP Q9H2K2 TNKS2_HUMAN 1114 1162 SEQADV 5C5R MET A 923 UNP Q9H2K2 INITIATING METHIONINE SEQADV 5C5R HIS A 924 UNP Q9H2K2 EXPRESSION TAG SEQADV 5C5R HIS A 925 UNP Q9H2K2 EXPRESSION TAG SEQADV 5C5R HIS A 926 UNP Q9H2K2 EXPRESSION TAG SEQADV 5C5R HIS A 927 UNP Q9H2K2 EXPRESSION TAG SEQADV 5C5R HIS A 928 UNP Q9H2K2 EXPRESSION TAG SEQADV 5C5R HIS A 929 UNP Q9H2K2 EXPRESSION TAG SEQADV 5C5R SER A 930 UNP Q9H2K2 EXPRESSION TAG SEQADV 5C5R SER A 931 UNP Q9H2K2 EXPRESSION TAG SEQADV 5C5R GLY A 932 UNP Q9H2K2 EXPRESSION TAG SEQADV 5C5R VAL A 933 UNP Q9H2K2 EXPRESSION TAG SEQADV 5C5R ASP A 934 UNP Q9H2K2 EXPRESSION TAG SEQADV 5C5R LEU A 935 UNP Q9H2K2 EXPRESSION TAG SEQADV 5C5R GLY A 936 UNP Q9H2K2 EXPRESSION TAG SEQADV 5C5R THR A 937 UNP Q9H2K2 EXPRESSION TAG SEQADV 5C5R GLU A 938 UNP Q9H2K2 EXPRESSION TAG SEQADV 5C5R ASN A 939 UNP Q9H2K2 EXPRESSION TAG SEQADV 5C5R LEU A 940 UNP Q9H2K2 EXPRESSION TAG SEQADV 5C5R TYR A 941 UNP Q9H2K2 EXPRESSION TAG SEQADV 5C5R PHE A 942 UNP Q9H2K2 EXPRESSION TAG SEQADV 5C5R GLN A 943 UNP Q9H2K2 EXPRESSION TAG SEQADV 5C5R SER A 944 UNP Q9H2K2 EXPRESSION TAG SEQADV 5C5R MET A 945 UNP Q9H2K2 EXPRESSION TAG SEQADV 5C5R MET B 923 UNP Q9H2K2 INITIATING METHIONINE SEQADV 5C5R HIS B 924 UNP Q9H2K2 EXPRESSION TAG SEQADV 5C5R HIS B 925 UNP Q9H2K2 EXPRESSION TAG SEQADV 5C5R HIS B 926 UNP Q9H2K2 EXPRESSION TAG SEQADV 5C5R HIS B 927 UNP Q9H2K2 EXPRESSION TAG SEQADV 5C5R HIS B 928 UNP Q9H2K2 EXPRESSION TAG SEQADV 5C5R HIS B 929 UNP Q9H2K2 EXPRESSION TAG SEQADV 5C5R SER B 930 UNP Q9H2K2 EXPRESSION TAG SEQADV 5C5R SER B 931 UNP Q9H2K2 EXPRESSION TAG SEQADV 5C5R GLY B 932 UNP Q9H2K2 EXPRESSION TAG SEQADV 5C5R VAL B 933 UNP Q9H2K2 EXPRESSION TAG SEQADV 5C5R ASP B 934 UNP Q9H2K2 EXPRESSION TAG SEQADV 5C5R LEU B 935 UNP Q9H2K2 EXPRESSION TAG SEQADV 5C5R GLY B 936 UNP Q9H2K2 EXPRESSION TAG SEQADV 5C5R THR B 937 UNP Q9H2K2 EXPRESSION TAG SEQADV 5C5R GLU B 938 UNP Q9H2K2 EXPRESSION TAG SEQADV 5C5R ASN B 939 UNP Q9H2K2 EXPRESSION TAG SEQADV 5C5R LEU B 940 UNP Q9H2K2 EXPRESSION TAG SEQADV 5C5R TYR B 941 UNP Q9H2K2 EXPRESSION TAG SEQADV 5C5R PHE B 942 UNP Q9H2K2 EXPRESSION TAG SEQADV 5C5R GLN B 943 UNP Q9H2K2 EXPRESSION TAG SEQADV 5C5R SER B 944 UNP Q9H2K2 EXPRESSION TAG SEQADV 5C5R MET B 945 UNP Q9H2K2 EXPRESSION TAG SEQRES 1 A 191 MET HIS HIS HIS HIS HIS HIS SER SER GLY VAL ASP LEU SEQRES 2 A 191 GLY THR GLU ASN LEU TYR PHE GLN SER MET LEU ASN THR SEQRES 3 A 191 SER GLY SER GLY THR ILE LEU ILE ASP LEU SER PRO ASP SEQRES 4 A 191 ASP LYS GLU PHE GLN SER VAL GLU GLU GLU MET GLN SER SEQRES 5 A 191 THR VAL ARG GLU HIS ARG ASP GLY GLY HIS ALA GLY GLY SEQRES 6 A 191 ILE PHE ASN ARG TYR ASN ILE LEU LYS ILE GLN LYS VAL SEQRES 7 A 191 CYS ASN LYS LYS LEU TRP GLU ARG TYR THR HIS ARG ARG SEQRES 8 A 191 LYS GLU VAL SER GLU GLU ASN HIS ASN HIS ALA ASN GLU SEQRES 9 A 191 ARG MET LEU PHE HIS GLY SER PRO PHE VAL ASN ALA ILE SEQRES 10 A 191 ILE HIS LYS GLY PHE ASP GLU ARG HIS ALA TYR ILE GLY SEQRES 11 A 191 GLY MET PHE GLY ALA GLY ILE TYR PHE ALA GLU ASN SER SEQRES 12 A 191 SER LYS SER ASN GLN TYR VAL TYR GLY ILE GLY GLY GLY SEQRES 13 A 191 THR GLY CYS PRO VAL HIS LYS ASP ARG SER CYS TYR ILE SEQRES 14 A 191 CYS HIS ARG GLN LEU LEU PHE CYS ARG VAL THR LEU GLY SEQRES 15 A 191 LYS SER PHE LEU GLN PHE SER ALA MET SEQRES 1 C 49 LYS MET ALA HIS SER PRO PRO GLY HIS HIS SER VAL THR SEQRES 2 C 49 GLY ARG PRO SER VAL ASN GLY LEU ALA LEU ALA GLU TYR SEQRES 3 C 49 VAL ILE TYR ARG GLY GLU GLN ALA TYR PRO GLU TYR LEU SEQRES 4 C 49 ILE THR TYR GLN ILE MET ARG PRO GLU GLY SEQRES 1 B 191 MET HIS HIS HIS HIS HIS HIS SER SER GLY VAL ASP LEU SEQRES 2 B 191 GLY THR GLU ASN LEU TYR PHE GLN SER MET LEU ASN THR SEQRES 3 B 191 SER GLY SER GLY THR ILE LEU ILE ASP LEU SER PRO ASP SEQRES 4 B 191 ASP LYS GLU PHE GLN SER VAL GLU GLU GLU MET GLN SER SEQRES 5 B 191 THR VAL ARG GLU HIS ARG ASP GLY GLY HIS ALA GLY GLY SEQRES 6 B 191 ILE PHE ASN ARG TYR ASN ILE LEU LYS ILE GLN LYS VAL SEQRES 7 B 191 CYS ASN LYS LYS LEU TRP GLU ARG TYR THR HIS ARG ARG SEQRES 8 B 191 LYS GLU VAL SER GLU GLU ASN HIS ASN HIS ALA ASN GLU SEQRES 9 B 191 ARG MET LEU PHE HIS GLY SER PRO PHE VAL ASN ALA ILE SEQRES 10 B 191 ILE HIS LYS GLY PHE ASP GLU ARG HIS ALA TYR ILE GLY SEQRES 11 B 191 GLY MET PHE GLY ALA GLY ILE TYR PHE ALA GLU ASN SER SEQRES 12 B 191 SER LYS SER ASN GLN TYR VAL TYR GLY ILE GLY GLY GLY SEQRES 13 B 191 THR GLY CYS PRO VAL HIS LYS ASP ARG SER CYS TYR ILE SEQRES 14 B 191 CYS HIS ARG GLN LEU LEU PHE CYS ARG VAL THR LEU GLY SEQRES 15 B 191 LYS SER PHE LEU GLN PHE SER ALA MET SEQRES 1 D 49 LYS MET ALA HIS SER PRO PRO GLY HIS HIS SER VAL THR SEQRES 2 D 49 GLY ARG PRO SER VAL ASN GLY LEU ALA LEU ALA GLU TYR SEQRES 3 D 49 VAL ILE TYR ARG GLY GLU GLN ALA TYR PRO GLU TYR LEU SEQRES 4 D 49 ILE THR TYR GLN ILE MET ARG PRO GLU GLY HET ZN A1201 1 HET 0E1 A1202 16 HET SO4 A1203 5 HET SO4 C1201 5 HET ZN B1201 1 HET 0E1 B1202 16 HET SO4 B1203 5 HET SO4 D1201 5 HETNAM ZN ZINC ION HETNAM 0E1 (7R)-2-HYDROXY-7-(PROPAN-2-YL)-7,8-DIHYDRO-5H-PYRANO[4, HETNAM 2 0E1 3-B]PYRIDINE-3-CARBONITRILE HETNAM SO4 SULFATE ION FORMUL 5 ZN 2(ZN 2+) FORMUL 6 0E1 2(C12 H14 N2 O2) FORMUL 7 SO4 4(O4 S 2-) FORMUL 13 HOH *521(H2 O) HELIX 1 AA1 ASP A 962 THR A 975 1 14 HELIX 2 AA2 ASN A 1002 ASN A 1020 1 19 HELIX 3 AA3 PHE A 1035 GLY A 1043 1 9 HELIX 4 AA4 ASP A 1045 ALA A 1049 5 5 HELIX 5 AA5 ASN A 1064 GLN A 1070 1 7 HELIX 6 AA6 GLY A 1074 GLY A 1078 5 5 HELIX 7 AA7 ARG C 1143 GLU C 1145 5 3 HELIX 8 AA8 ASP B 962 THR B 975 1 14 HELIX 9 AA9 ASN B 1002 GLU B 1019 1 18 HELIX 10 AB1 PHE B 1035 GLY B 1043 1 9 HELIX 11 AB2 ASP B 1045 ALA B 1049 5 5 HELIX 12 AB3 ASN B 1064 GLN B 1070 1 7 HELIX 13 AB4 GLY B 1074 GLY B 1078 5 5 HELIX 14 AB5 ARG D 1143 GLU D 1145 5 3 SHEET 1 AA1 5 ILE A 954 ASP A 957 0 SHEET 2 AA1 5 TYR A 992 CYS A1001 -1 O CYS A1001 N ILE A 954 SHEET 3 AA1 5 ALA C1147 ILE C1157 -1 O GLN C1156 N ASN A 993 SHEET 4 AA1 5 ARG A1094 THR A1102 -1 N ARG A1094 O TYR C1155 SHEET 5 AA1 5 GLU A1026 HIS A1031 -1 N LEU A1029 O CYS A1099 SHEET 1 AA2 4 ILE A1059 ALA A1062 0 SHEET 2 AA2 4 GLU C1138 ILE C1141 -1 O ILE C1141 N ILE A1059 SHEET 3 AA2 4 SER C1124 PRO C1129 -1 N GLY C1127 O GLU C1138 SHEET 4 AA2 4 SER A1106 SER A1111 1 N PHE A1107 O THR C1126 SHEET 1 AA3 5 ILE B 954 ASP B 957 0 SHEET 2 AA3 5 TYR B 992 CYS B1001 -1 O LYS B 999 N ILE B 956 SHEET 3 AA3 5 ALA D1147 ILE D1157 -1 O GLN D1156 N ASN B 993 SHEET 4 AA3 5 ARG B1094 THR B1102 -1 N ARG B1094 O TYR D1155 SHEET 5 AA3 5 GLU B1026 HIS B1031 -1 N LEU B1029 O CYS B1099 SHEET 1 AA4 4 ILE B1059 ALA B1062 0 SHEET 2 AA4 4 GLU D1138 ILE D1141 -1 O ILE D1141 N ILE B1059 SHEET 3 AA4 4 SER D1124 PRO D1129 -1 N GLY D1127 O GLU D1138 SHEET 4 AA4 4 SER B1106 SER B1111 1 N PHE B1107 O THR D1126 LINK SG CYS A1081 ZN ZN A1201 1555 1555 2.34 LINK ND1 HIS A1084 ZN ZN A1201 1555 1555 2.16 LINK SG CYS A1089 ZN ZN A1201 1555 1555 2.41 LINK SG CYS A1092 ZN ZN A1201 1555 1555 2.33 LINK SG CYS B1081 ZN ZN B1201 1555 1555 2.36 LINK ND1 HIS B1084 ZN ZN B1201 1555 1555 2.16 LINK SG CYS B1089 ZN ZN B1201 1555 1555 2.46 LINK SG CYS B1092 ZN ZN B1201 1555 1555 2.40 SITE 1 AC1 4 CYS A1081 HIS A1084 CYS A1089 CYS A1092 SITE 1 AC2 12 HIS A1031 GLY A1032 ALA A1049 TYR A1050 SITE 2 AC2 12 TYR A1060 PHE A1061 ALA A1062 LYS A1067 SITE 3 AC2 12 SER A1068 TYR A1071 HOH A1403 HOH C1302 SITE 1 AC3 8 ARG A 977 HIS A 979 ARG A 980 LYS A1067 SITE 2 AC3 8 GLN A1070 HOH A1379 HOH C1314 HOH C1317 SITE 1 AC4 5 ASN A 990 ARG A 991 HOH A1355 PRO C1160 SITE 2 AC4 5 GLU C1161 SITE 1 AC5 4 CYS B1081 HIS B1084 CYS B1089 CYS B1092 SITE 1 AC6 11 HIS B1031 GLY B1032 TYR B1050 TYR B1060 SITE 2 AC6 11 PHE B1061 ALA B1062 LYS B1067 SER B1068 SITE 3 AC6 11 TYR B1071 HOH B1427 HOH D1307 SITE 1 AC7 8 ARG B 977 HIS B 979 ARG B 980 LYS B1067 SITE 2 AC7 8 HOH B1356 HOH B1449 HOH D1305 HOH D1308 SITE 1 AC8 6 ASN B 990 ARG B 991 PRO D1160 GLU D1161 SITE 2 AC8 6 HOH D1306 HOH D1311 CRYST1 91.205 98.114 119.334 90.00 90.00 90.00 C 2 2 21 16 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.010964 0.000000 0.000000 0.00000 SCALE2 0.000000 0.010192 0.000000 0.00000 SCALE3 0.000000 0.000000 0.008380 0.00000